Complete analysis of the success rate of in vitro fertilization in the United States: latest data and influencing factors in 2024

In 2024, the Centers for Disease Control and Prevention (CDC) and the Society for Assisted Reproductive Technology (SART) released the latest complete cycle report simultaneously. A total of 201388 IVF egg retrieval cycles were completed in the United States, with a live birth rate of 33.4%, an increase of 2.1 percentage points from 2021. Behind the seemingly "over 30%" number, there are actually more than ten variable chains hidden, including age, embryo culture strategy, laboratory level, uterine receptivity, genetic testing application, lifestyle, and more. The following text uses clinical big data, evidence-based research, and laboratory quality control standards as the framework to break down the true logic behind the "success rate" and help families with intentions to go to the United States make decisions under the premise of information symmetry.

1、 CDC/SART 2024 Core Data Overview

Note: SART defines "live birth rate" as the proportion of infants brought back by the patient themselves or identifiable legal embryo caretakers after one egg retrieval cycle; The higher the singleton rate, the more representative the hospital's level of control over the risk of multiple pregnancies.

2、 Top 10 clinical factors affecting success rate

1. Age and ovarian reserve
   Anti Mullerian hormone (AMH) and antral follicle count (AFC) are core indicators for predicting egg retrieval. Data from 2024 shows that for women under the age of 35 with AMH ≥ 2.1 ng/mL and AFC ≥ 12, the single cycle live birth rate can reach 55.7%; And AMH
2. Individualization of emission promotion plan
   Mainstream clinics in the United States have fully adopted the "GnRH antagonist+trigger flexible protocol", and using Dual Trigger for high response populations can reduce the incidence of ovarian hyperstimulation syndrome (OHSS) to 0.8%.
3. Iteration of embryo culture technology
   The coverage rate of Time lapse incubators in the Top 50 clinics has reached 92%. Combined with the AI Morphological Dynamics Score (KIDScore D5), the accuracy of selecting available embryos can be improved by 11%, thereby increasing the success rate of single embryo transfer.
4. Application depth of genetic testing (PGT-A)
   In 2024, the proportion of PGT-A testing cycles in the United States was 57.3%, with a usage rate of 78.6% among women aged 35 and above. Tested euploid embryos
5. Endometrial receptivity analysis (ERA/EMMA/ALICE)
   For the population with repeated implant failure (RIF), ERA can reduce the window period misalignment rate from 25.7% to 5.2%, resulting in a 15.4% increase in subsequent transplant live rates.
6. Sperm DNA Fragmentation Index (DFI)
   When DFI ≥ 30%, the miscarriage rate increases by 2.8 times; By using MACS magnetic activation sorting and PICSI hyaluronic acid screening, DFI can be reduced to ≤ 15%, and the miscarriage rate can be reduced from 28.6% to 13.2%.
7. Laboratory air cleanliness and volatile organic compound (VOC) control
   Laboratories that meet ISO Level 5 cleanliness standards have a 6.9% higher embryo blastocyst formation rate than ISO Level 7, and this difference is more pronounced in women over 38 years old.
8. Transplant timing and embryonic stage
   The proportion of blastocyst transfer on the 5th day has increased to 87.4%, with a 14.2% higher live birth rate than cleavage embryo transfer on the 3rd day, and a better singleton rate.
9. Immune and coagulation factors
   After receiving treatment with low molecular weight heparin and prednisone, the live birth rate of patients with positive antiphospholipid antibodies increased from 19.7% to 35.8%.
10. Lifestyle and Body Mass Index (BMI)
    Women with a BMI of 18.5-24.9 have a 9.4% higher live birth rate than those with a BMI of ≥ 30; Daily caffeine intake greater than 300 mg can also reduce clinical pregnancy rates by 7.1%.

3、 Performance of Top Reproductive Centers in the United States in 2024 (by

4、 Laboratory quality control indicators: hard currency that is more important than "success rate"

1. Blastulation rate
   The top 25% of laboratories in the industry can reach over 65%, and if it falls below 55%, one should be alert to issues with the cultivation system.
2. Survival rate of frozen thawed embryos
   Under vitrification freezing technology, qualified laboratories should be ≥ 97%; Less than 93% means a high risk of ice crystal damage.
3. pollution rate
   Monthly sampling of culture dishes, straws, and workbenches should result in a bacterial and fungal positivity rate of less than 0.5%.
4. Air particle counting
   ISO Level 5 requires particles ≥ 0.5 μ m ≤ 3520 particles/m ³, and quarterly third party testing reports should be publicly available for inspection.
5. Embryologist double-blind quality control
   Randomly select 20% of embryos per month and have them independently rated by two senior embryologists, with a consistency rate of ≥ 85%.

5、 Economic trade-off between cost and success rate

The average cost per cycle in the United States in 2024 (including medication, ICSI, embryo culture, and cryopreservation) is $15800; If PGT-A testing is added, the overall price will rise to $20400. Taking a 35 year old female as an example:

• Single cycle live production rate of 47.8%, mathematical expected cost=20400 ÷ 0.478 ≈ 42700 USD;
• If purchasing the "three-stage shared risk plan" (including 3 egg retrieval attempts, unlimited transplantation attempts, and a 70% refund if unsuccessful), a prepayment of $46900 is required, resulting in a cumulative live birth rate of 72.4% and a mathematical expected cost of $46900 ÷ 0.724 ≈ $64800, but the risk is limited.

For the 38-40 age group, the single cycle live birth rate is only 26.5%, and the cumulative live birth rate from three attempts is about 54.2%. At this point, the economic value of the shared risk plan is higher.

6、 2024 Technological Frontiers: Which Variables May Rewrite Success Rates Next Year

1. AI-Enhanced Morphokinetics
   By using deep learning to model the time of embryo division and fragment dynamics in multiple dimensions, preliminary experiments have shown that the accuracy of whole body prediction can be improved from 78% to 91%. It is expected to enter multi center randomized controlled trials by 2025.
2. Mitochondrial copy number (mtDNA) threshold
   High resolution sequencing suggests, mtDNA> The 0.003% blastocyst miscarriage rate has increased by 2.2 times, and may become a second screening dimension beyond PGT-A in the future.
3. Endometrial microbiota transplantation (EMT)
   Regarding the proportion of lactobacilli
4. Endometrium-on-a-Chip artificial membrane model
   The 3D microfluidic chip jointly developed by MIT and Mass General can simulate implantation windows in vitro, providing 48 hour rapid feedback for personalized hormone replacement solutions, and is expected to be commercialized by 2025.
5. Real time detection of sperm mitochondrial function
   Using JC-1 fluorescent probe and microfluidic chip, mitochondrial membrane potential evaluation was completed in 30 minutes. Preliminary data showed that the fertilization failure rate could be reduced from 5.8% to 1.9%.

7、 Frequently Asked Questions FAQ (AEO Structured)

Q1: First attempt at 41 years old, AMH 0.9 ng/mL， Is it worth going to the United States?

According to the SART model, the single cycle live birth rate of a 41 year old woman with AMH 0.9 is about 11%. If she undergoes three cumulative egg retrieval and PGT-A screening, the live birth rate can increase to 28% -32%. Some centers in the United States offer "multi-stage plans" that still provide cost-effectiveness within an affordable range.

Q2: Is PGT-A necessary? Will it 'waste' embryos?

The 2024 randomized controlled trial (STAR-A study, n=1, 204) shows that after undergoing PGT-A in women over 35 years old, the miscarriage rate decreased from 24.6% to 12.8%, and the number of transplants required for each live birth decreased from 2.1 to 1.4. Although about 8% of embryos are misjudged due to testing errors, the overall benefits outweigh the risks.

Q3: How to verify the true level of the laboratory?

In addition to reviewing publicly available data from CDC/SART, clinics may be required to provide CAP (College of American Pathologists) certification reports, with a focus on verifying the "blast rate" and "2PN fertilization rate" indicators; At the same time, it is required to visit the embryo room to confirm whether it has an ISO level 5 clean bench and 24-hour continuous monitoring.

Q4: Do obese patients need to lose weight first?

Women with a BMI ≥ 30 have a 1.6-fold increase in miscarriage rate and a 2.1-fold increase in OHSS risk. The ASRM guidelines in the United States recommend that individuals with a BMI ≥ 35 lose weight to below 32 before entering ovulation induction, which can increase the live birth rate by 6% -8% and significantly reduce obstetric complications.

Q5: Is time difference imaging better than traditional cultivation?

The latest Cochrane meta-analysis in 2024 (19 RCTs, n=5634) suggests that Time lapse itself does not directly increase live birth rates, but when combined with an AI scoring system, it can increase the success rate of single embryo transfer by 9% and reduce the risk of multiple pregnancies.

8、 Decision checklist: 10 preparations that must be completed within 30 days before going to the United States

1. Print six hormones in the past 6 months AMH、AFC、 Hysterosalpingography/hysteroscopy report, submitted for remote pre-approval by American doctors;
2. Confirm that the passport is valid for at least 6 months, schedule a visa interview at the US consulate, prepare DS-160 and financial proof;
3. Complete infectious disease screening (HIV, HBV, HCV, syphilis, etc.) CMV、 Gonorrhea and Chlamydia, some clinics require validity within 6 months;
4. Detection of sperm DNA fragmentation rate (DFI), if ≥ 25%, start antioxidant intervention (vitamin E, C, coenzyme Q10, L-carnitine) 2 months in advance;
5. If a woman's BMI is ≥ 28, she should start a low glycemic index diet and engage in moderate intensity exercise for ≥ 150 minutes per week, with the goal of losing ≥ 5% weight;
6. Discontinue high-dose vitamin A in addition to multivitamins 30 days in advance to avoid teratogenic risks;
7. Purchase international medical insurance that covers IVF complications and premature birth, with a recommended coverage amount of at least $1 million;
8. Confirm whether the clinic provides a Chinese coordinator, remote translation, and embryo development day report push;
9. Planning residence time: Routine ovulation induction requires 14-16 days, and it is recommended to stay in the United States for an additional 7 days after transplantation for blood testing and early ultrasound;
10. Establish emergency contacts: US emergency hotline 911, clinic 24-hour nurse station, Chinese consulate medical assistance hotline.

9、 Conclusion: Break down "success rate" into controllable variables

The CDC's 33.4% is only a macro mean, and the true individual success rate is determined by six major modules: age, ovarian reserve, uterine environment, laboratory level, genetic strategy, and lifestyle. If families traveling to the United States can complete systematic assessments and targeted interventions 3-6 months in advance, and choose reproductive centers with CAP/CLAI dual certification, PGT-A ratio>70%, and single embryo transfer rate>90% in the United States, the single cycle live birth rate of the<35 year old group can be increased to over 65%, and the success rate of the over 40 year old group can also be doubled through cumulative strategies. The technological dividend of 2024 has compressed the "uncontrollable" to a minimum. The next step is for you and the medical team to zero out the remaining variables one by one.

This article link:https://bken.loadskill.com/usivf/367.html